$heff's $tation of $tocks & $olid DD

[$heff]

$ASH 2014..Wedbush discusses key data releases:

-bluebird (BLUE): updates from Phase I/II LentiGlobin studies (HGB-204/Northstar and HGB-205) in beta-thal

-Epizyme (EPZM): additional preclinical and Ph 1 data of EPZ-5676 and potential top-line Ph 1 data of EPZ-6438

-Foundation Medicine (FMI): additional FoundationOne publications likely to be presented

-Karyopharm (KPTI): additional data of Selinexor in multiple myeloma and non-Hodgkin's lymphoma

-MEI (MEIP): data from Ph 2 pracinostat/Vidaza combo study in elderly AML

Pharmacyclics (PCYC): data from studies of Imbruvica in del17p r/r CLL/SLL, follicular lymphoma and MM
Stemline (STML): preclinical data for SL-401, SL-501 and SL-101
Xencor (XNCR): data from Ph 2 trials of XmAb5574/MOR208 in ALL and NHL